64x Bio

About:

64x Bio builds a platform that increases the speed and scale of mammalian cell line discovery.

Twitter/X: 64xbio

Top Investors: BoxGroup, Y Combinator, Refactor, Northpond Ventures, Liquid 2 Ventures

Description:

64x Bio builds a platform that increases the speed and scale of mammalian cell line discovery. The company uses a throughput discovery and screening platform and an integrated computational design loop, they develop new ways of generating highly optimized and otherwise unattainable cell lines for the manufacturing of viral vectors, with a specific focus on those used for cell and gene therapies.

Total Funding Amount:

$59.5M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2017-08-22

Contact Email:

team(AT)64xbio.com

Founders:

Alexis Rovner, David Thompson, Jeffrey Way, Pamela Silver

Number of Employees:

11-50

Last Funding Date:

2022-01-19

IPO Status:

Private

Industries: